These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 22917608

  • 1. Effects of valproic acid on the expression of trophic factors in human bone marrow mesenchymal stromal cells.
    Cho GW, Kang BY, Kim KS, Kim SH.
    Neurosci Lett; 2012 Sep 27; 526(2):100-5. PubMed ID: 22917608
    [Abstract] [Full Text] [Related]

  • 2. Valproic acid promotes neuronal differentiation by induction of neuroprogenitors in human bone-marrow mesenchymal stromal cells.
    Jeong SG, Ohn T, Kim SH, Cho GW.
    Neurosci Lett; 2013 Oct 25; 554():22-7. PubMed ID: 24021810
    [Abstract] [Full Text] [Related]

  • 3. Proteomic analysis reveals KRIT1 as a modulator for the antioxidant effects of valproic acid in human bone-marrow mesenchymal stromal cells.
    Jung KH, Han DM, Jeong SG, Choi MR, Chai YG, Cho GW.
    Drug Chem Toxicol; 2015 Oct 25; 38(3):286-92. PubMed ID: 25203678
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. HIV protease inhibitors induce senescence and alter osteoblastic potential of human bone marrow mesenchymal stem cells: beneficial effect of pravastatin.
    Hernandez-Vallejo SJ, Beaupere C, Larghero J, Capeau J, Lagathu C.
    Aging Cell; 2013 Dec 25; 12(6):955-65. PubMed ID: 23795945
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities.
    Ponte AL, Marais E, Gallay N, Langonné A, Delorme B, Hérault O, Charbord P, Domenech J.
    Stem Cells; 2007 Jul 25; 25(7):1737-45. PubMed ID: 17395768
    [Abstract] [Full Text] [Related]

  • 11. Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling.
    Longobardi L, O'Rear L, Aakula S, Johnstone B, Shimer K, Chytil A, Horton WA, Moses HL, Spagnoli A.
    J Bone Miner Res; 2006 Apr 25; 21(4):626-36. PubMed ID: 16598383
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Preconditioning mesenchymal stem cells with the mood stabilizers lithium and valproic acid enhances therapeutic efficacy in a mouse model of Huntington's disease.
    Linares GR, Chiu CT, Scheuing L, Leng Y, Liao HM, Maric D, Chuang DM.
    Exp Neurol; 2016 Jul 25; 281():81-92. PubMed ID: 27085395
    [Abstract] [Full Text] [Related]

  • 17. Transduction of human EPO into human bone marrow mesenchymal stromal cells synergistically enhances cell-protective and migratory effects.
    Kim MH, Cho GW, Huh YM, Kim SH.
    Mol Biol (Mosk); 2010 Jul 25; 44(4):656-63. PubMed ID: 20873225
    [Abstract] [Full Text] [Related]

  • 18. Toll-like receptors 2 and 4 mediate the capacity of mesenchymal stromal cells to support the proliferation and differentiation of CD34⁺ cells.
    Wang X, Cheng Q, Li L, Wang J, Xia L, Xu X, Sun Z.
    Exp Cell Res; 2012 Feb 01; 318(3):196-206. PubMed ID: 22100911
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.